The dosing of subcutaneous terbutaline pump tocolytic therapy is critical.
Lam
F
F
D009202:Cardiomyopathies / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015918:Infusion Pumps, Implantable; D011247:Pregnancy; D013726:Terbutaline / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D015149:Tocolytic Agents / Q000008:administration & dosage* / Q000627:therapeutic use
D015149:Tocolytic Agents; D013726:Terbutaline